دورية أكاديمية
Prospective validation of a biomarker-driven response prediction model to romiplostim in lower-risk myelodysplastic neoplasms – results of the EUROPE trial by EMSCO
| العنوان: | Prospective validation of a biomarker-driven response prediction model to romiplostim in lower-risk myelodysplastic neoplasms – results of the EUROPE trial by EMSCO |
|---|---|
| المؤلفون: | Kubasch, Anne SophieAff1, Aff2, Aff3, Giagounidis, AristotelesAff2, Aff3, Aff4, Metzgeroth, Georgia, Jonasova, Anna, Herbst, Regina, Diaz, Jose Miguel Torregrosa, De Renzis, Benoit, Götze, Katharina S.Aff2, Aff3, Aff10, Huetter-Kroenke, Marie-Luise, Gourin, Marie-Pierre, Slama, Borhane, Dimicoli-Salazar, Sophie, Cony-Makhoul, Pascale, Laribi, Kamel, Park, Sophie, Jersemann, Katja, Schipp, Dorothea, Metzeler, Klaus H.Aff1, Aff2, Aff3, Tiebel, Oliver, Sockel, KatjaAff2, Aff3, Aff21, Gloaguen, SilkeAff1, Aff2, Aff3, Aff18, Mies, Anna, Chermat, Fatiha, Thiede, Christian, Sapena, Rosa, Schlenk, Richard F.Aff23, Aff24, Fenaux, PierreAff3, Aff22, Aff25, Platzbecker, UweAff1, Aff2, Aff3, IDs4137502201669z_cor28, Adès, LionelAff3, Aff22, Aff25 |
| المصدر: | Leukemia. 36(10):2519-2527 |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 08876924 14765551 |
|---|---|
| DOI: | 10.1038/s41375-022-01669-z |